Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX – Get Free Report)’s share price passed below its two hundred day moving average during trading on Tuesday . The stock has a two hundred day moving average of $0.41 and traded as low as $0.0952. Eagle Pharmaceuticals shares last traded at $0.44, with a volume of 799 shares trading hands.
Eagle Pharmaceuticals Stock Down 15.9%
The company has a market cap of $4.81 million, a P/E ratio of 0.31 and a beta of 0.83. The stock has a 50 day moving average price of $0.58 and a two-hundred day moving average price of $0.41.
About Eagle Pharmaceuticals
Eagle Pharmaceuticals, Inc is a specialty pharmaceutical company headquartered in Woodcliff Lake, New Jersey, that focuses on the development, manufacturing and commercialization of hospital-administered therapies in the areas of critical care, oncology and rare diseases. Founded in 2007, Eagle has built expertise in complex injectable formulations and orphan drug designation, aiming to address unmet medical needs through both novel products and reformulated generics.
The company’s marketed portfolio in the United States includes Bendeka®, an intravenous formulation of bendamustine for certain types of leukemia and lymphoma; Beleodaq®, approved for relapsed or refractory peripheral T-cell lymphoma; and Empaveli®, a complement inhibitor for the treatment of paroxysmal nocturnal hemoglobinuria.
Featured Stories
- Five stocks we like better than Eagle Pharmaceuticals
- Premium Retail’s Stress Test Is Separating Winners From Losers
- D-Wave Quantum or a Quantum ETF: Which Is the Better Bet?
- GE Vernova Just Sent a Mixed AI Signal to Investors
- Alphabet Crushed Earnings, But One Number Spooked the Market
Receive News & Ratings for Eagle Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eagle Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
